Composition
Palonosetron Injection
Interested in this product?
Contact us for export pricing, bulk orders, and regulatory documentation.
Request QuoteProduct Overview
Palonoberg contains Palonosetron, a second-generation 5-HT3 antagonist with the longest half-life in its class, effective against both acute and delayed CINV.
Indication
Prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of emetogenic chemotherapy.
Packaging
Single vial pack
Storage
Store below 25°C, protected from light. Use reconstituted solution as directed.
Export Ready
Available for export with full regulatory documentation, COA, and dossier support for international registration.
Disclaimer: This product information is intended for healthcare professionals and authorized distributors only. It is not intended as medical advice. Please refer to the full prescribing information for complete details. Regulatory approvals may vary by country.